Clinical Trial

Hypersomnia in the Paediatric Population

Study acronym: SOMNO-PED
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a 36-month, multicentric, cross-sectional study involving a paediatric population aged 6 to 17 years. Three groups will be included: Group A: children from the general population with no complaints of sleepiness; Group B: children with a sleep disorder or excessive sleepiness associated with a medical condition (narcolepsy, circadian rhythm sleep disorder (CRSD), non-REM parasomnias, attention deficit disorder with or without hyperactivity (ADHD), autism spectrum disorder (ASD) or obesity); Group C: healthy volunteers with no medical conditions or sleep-related complaints.
Trial Details
NCT Number NCT07766343
Lead Sponsor University Hospital, Montpellier
Collaborators: Société Française de Recherche et de Médecine du Sommeil
Conditions Wakefulness Disorder, Narcolepsy, Idiopathic Hypersomnia
Enrollment 760 participants
Start Date 2026-09
Primary Completion 2029-05 (estimated)
Study Completion 2029-11 (estimated)
Updated on ClinicalTrials.gov 2026-08-14